www.fdanews.com/articles/142254-fda-extends-taliglucerase-alfa-pdufa-date-to-may-1-2012
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012
December 6, 2011
Protalix BioTherapeutics announced it received notification that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application for taliglucerase alfa to May 1, 2012, a three-month extension from the previous date.
The Sacramento Bee
The Sacramento Bee